Drugs / AFX5931
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03703895 Comparator | Sep 2018 → Apr 2019 | hand dermatosis | The Center for Clinical and Cosmetic Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AFX5931 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03703895 ↗ |
| Modality | Small molecule | “a medication combining a small, potent anti-inflammatory molecule” NCT03703895 ↗ |
| Route | Topical | “Topical AFX5931 will be applied twice daily for 28 days.” NCT03703895 ↗ |